ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the field of biopharmaceuticals, offering promising enhancements across different clinical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, more reliable alternate for therapeutic use, notably in